155 related articles for article (PubMed ID: 25796164)
1. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients.
Huan C; Cui G; Lu C; Qu X; Han T
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164
[TBL] [Abstract][Full Text] [Related]
2. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases.
Wang M; Mou C; Jiang M; Han L; Fan S; Huan C; Qu X; Han T; Qu Y; Xu G
Eur J Endocrinol; 2012 May; 166(5):797-802. PubMed ID: 22334636
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients.
Guo X; Zhang R; Zhang D; Wang Z; Gao L; Yao Y; Deng K; Bao X; Feng M; Xu Z; Yang Y; Lian W; Wang R; Ma W; Xing B
Front Endocrinol (Lausanne); 2021; 12():807054. PubMed ID: 35154007
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
[TBL] [Abstract][Full Text] [Related]
6. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
Park SH; Ku CR; Moon JH; Kim EH; Kim SH; Lee EJ
J Clin Endocrinol Metab; 2018 Mar; 103(3):909-916. PubMed ID: 29272449
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia in Acromegaly is Related to Prolactin Secretion by Somatolactotroph Tumours.
Van Laethem D; Michotte A; Cools W; Velkeniers B; Unuane D; Andreescu CE; Bravenboer B
Horm Metab Res; 2020 Sep; 52(9):647-653. PubMed ID: 32757187
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.
Fusco A; Zatelli MC; Bianchi A; Cimino V; Tilaro L; Veltri F; Angelini F; Lauriola L; Vellone V; Doglietto F; Ambrosio MR; Maira G; Giustina A; degli Uberti EC; Pontecorvi A; De Marinis L
J Clin Endocrinol Metab; 2008 Jul; 93(7):2746-50. PubMed ID: 18460561
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases].
Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y
Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
11. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ki-67, p53 and vascular endothelial growth factor (VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior ?
Yarman S; Kurtulmus N; Canbolat A; Bayindir C; Bilgic B; Ince N
Neuro Endocrinol Lett; 2010; 31(6):823-8. PubMed ID: 21196926
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
Lee CC; Vance ML; Lopes MB; Xu Z; Chen CJ; Sheehan J
Pituitary; 2015 Jun; 18(3):326-34. PubMed ID: 24925503
[TBL] [Abstract][Full Text] [Related]
14. The role of Ki-67 in women with a resistant prolactinoma: a retrospective analysis in 199 hospitalized patients over a period of 5 years.
Lu C; Ren Z; Huan C; Cui G
Pak J Pharm Sci; 2014 Jul; 27(4 Suppl):1075-81. PubMed ID: 25016269
[TBL] [Abstract][Full Text] [Related]
15. Transphenoidal surgery in acromegalic patients: anatomical considerations and potential pitfalls.
Carrabba G; Locatelli M; Mattei L; Guastella C; Mantovani G; Rampini P; Gaini SM
Acta Neurochir (Wien); 2013 Jan; 155(1):125-30; discussion 130. PubMed ID: 23180167
[TBL] [Abstract][Full Text] [Related]
16. An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.
Attanasio R; Montini M; Valota M; Cortesi L; Barbò R; Biroli F; Tonnarelli G; Albizzi M; Testa RM; Pagani G
Pituitary; 2008; 11(1):1-11. PubMed ID: 17690987
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
Shi S; Zhang L; Yu Y; Wang C; Li J
BMC Endocr Disord; 2021 May; 21(1):90. PubMed ID: 33933067
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
19. [Diabetic ketoacidosis as the first manifestation of a mixed growth hormone and prolactin-secreting tumor].
Carrasco de la Fuente M; González-Albarrán O; Pérez López G; Cano Megías M
Endocrinol Nutr; 2010 Dec; 57(10):507-9. PubMed ID: 20705526
[No Abstract] [Full Text] [Related]
20. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]